Preparation, Optimization, and In-Vitro Evaluation of Brusatol- and Docetaxel-Loaded Nanoparticles for the Treatment of Prostate Cancer
Challenges to docetaxel use in prostate cancer treatment include several resistance mechanisms as well as toxicity. To overcome these challenges and to improve the therapeutic efficacy in heterogeneous prostate cancer, the use of multiple agents that can destroy different subpopulations of the tumor...
Main Authors: | Tayo Alex Adekiya, Madison Moore, Michael Thomas, Gabriel Lake, Tamaro Hudson, Simeon K. Adesina |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/16/1/114 |
Similar Items
-
Synthesis and cytotoxicity evaluation of fluorinated brusatol, bruceosin, and dehydrobrusatol
by: Yukio Hitotsuyanagi, et al.
Published: (2023-01-01) -
Brusatol inhibits proliferation, migration, and invasion of nonsmall cell lung cancer PC-9 cells
by: Lu-Ming Yang, et al.
Published: (2023-01-01) -
Targeting tumor glycolysis metabolism in oral squamous cell carcinoma cells by brusatol
by: Guilian Zhang, et al.
Published: (2022-12-01) -
HOXB9 a miR-122–5p regulated gene, suppressed the anticancer effects of brusatol by upregulating SCD1 expression in melanoma
by: Ziming Guo, et al.
Published: (2023-06-01) -
Brusatol modulates diverse cancer hallmarks and signaling pathways as a potential cancer therapeutic
by: Song-Bin Guo, et al.
Published: (2022-07-01)